Close to one-third of drugs approved by the FDA are found to have safety problems, according to a research report from The Journal of the American Medical Association.

JAMA’s report stated that these safety issues, known as “postmarket safety events,” are “common after FDA approval, highlighting the importance of continuous monitoring of the safety of novel therapeutics throughout their life cycle.”

Every single day in the United States, 1,000 people are treated in emergency departments for a single FDA-approved drug—opioids. Opioid drug overdoses now kill more people annually than the number of Americans who died in the Vietnam war.

However, it’s not only opioids. Acetaminophen overdose is actually the leading cause for calls to Poison Control Centers across the US—more than 100,000 instances per year—and, each year, is responsible for: More than 56,000 emergency room visits. 2,600 hospitalizations. An estimated 458 deaths due to acute liver failure.

According to some estimates, Antidepressants, which are handed out like candy with the FDA’s blessing, cause over 40,000 deaths per year.

The death toll from the three aforementioned medications tops 100,000 annually, yet still there are countless others.

The study sought to identify the “frequency of postmarket safety events” of FDA-approved drugs. It revealed that 222 “novel therapeutics” were approved by the FDA between 2001 and 2010. Out of those 222 FDA-approved products, there were 123 safety issues later found in 71, or 32 percent, of the approved drugs. Actions taken for the 71 drugs included withdrawal of the substance, new safety announcements highlighting discovered risks, and issuing “black box” warnings…..more here